このページの翻訳は実験的なもので、現在開発中です。お待ちしております!
SIGA Technologies 過去の業績
過去 基準チェック /46
SIGA Technologiesの収益は年間平均-39.3%の割合で減少していますが、 Pharmaceuticals業界の収益は年間 減少しています。収益は年間0.4% 16.7%割合で 減少しています。 SIGA Technologiesの自己資本利益率は48%であり、純利益率は50.5%です。
主要情報
-39.3%
収益成長率
-36.0%
EPS成長率
Pharmaceuticals 業界の成長 | 6.0% |
収益成長率 | -16.7% |
株主資本利益率 | 48.0% |
ネット・マージン | 50.5% |
前回の決算情報 | 31 Mar 2024 |
最近の業績更新
Recent updates
SIGA Technologies: BARDA Contract Renewal Required To Sustain Recent Momentum (Rating Downgrade)
Jun 13SIGA Technologies, Inc. (NASDAQ:SIGA) Stock Rockets 64% But Many Are Still Ignoring The Company
Mar 31Siga Technologies: Preparing For A Contingency If Tomorrow Comes
Mar 25Shareholders Can Be Confident That SIGA Technologies' (NASDAQ:SIGA) Earnings Are High Quality
Mar 19The Price Is Right For SIGA Technologies, Inc. (NASDAQ:SIGA)
Feb 15Do SIGA Technologies' (NASDAQ:SIGA) Earnings Warrant Your Attention?
Jan 13SIGA Technologies secures new contract awarded to procure up to $10.7M of TPOXX
Sep 29Siga monkeypox therapy undergoes NIH-led late-stage trial
Sep 09Scientists behind key COVID study run monkeypox trial for SIGA therapy
Aug 23SIGA to activate first trial sites for monkeypox therapy in U.K. next week – Bloomberg
Aug 17Estimating The Fair Value Of SIGA Technologies, Inc. (NASDAQ:SIGA)
Aug 12SIGA to deliver $26M of monkeypox therapy to U.S. in 2023 after option exercise
Aug 09SIGA Technologies: Unjustified Selloff, Loading The Boat, Best Monkeypox Play
Aug 01SIGA Technologies: Buy Monkeypox
Jul 25Siga Technologies receives approval from UK for tecovirimat
Jul 08SIGA Technologies: Solid Business With Means To Address Monkeypox Outbreak
May 27SIGA Technologies: There's An Assured Market For A Smallpox Vaccine
Dec 12It's Probably Less Likely That SIGA Technologies, Inc.'s (NASDAQ:SIGA) CEO Will See A Huge Pay Rise This Year
Jun 08SIGA Technologies: Biodefense Pharma Unlocks New Value Abroad For TPOXX
Apr 28Introducing SIGA Technologies (NASDAQ:SIGA), The Stock That Soared 880% In The Last Five Years
Feb 22We're Not So Sure You Should Rely on SIGA Technologies' (NASDAQ:SIGA) Statutory Earnings
Feb 02SIGA Technologies +4% AH, announces Canada contract to purchase up to ~$33M of oral TPOXX
Jan 13Is SIGA Technologies, Inc.'s (NASDAQ:SIGA) Latest Stock Performance Being Led By Its Strong Fundamentals?
Jan 12Read This Before Buying SIGA Technologies, Inc. (NASDAQ:SIGA) Shares
Dec 22収支内訳
収支内訳
SIGA Technologies の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
---|---|---|---|---|
31 Mar 24 | 157 | 79 | 26 | 0 |
31 Dec 23 | 140 | 68 | 22 | 0 |
30 Sep 23 | 35 | -5 | 21 | 0 |
30 Jun 23 | 98 | 28 | 34 | 0 |
31 Mar 23 | 109 | 33 | 36 | 0 |
31 Dec 22 | 111 | 34 | 35 | 0 |
30 Sep 22 | 215 | 108 | 33 | 0 |
30 Jun 22 | 147 | 72 | 18 | 0 |
31 Mar 22 | 139 | 70 | 18 | 0 |
31 Dec 21 | 134 | 69 | 18 | 0 |
30 Sep 21 | 56 | 16 | 18 | 0 |
30 Jun 21 | 95 | 44 | 17 | 0 |
31 Mar 21 | 127 | 64 | 15 | 0 |
31 Dec 20 | 125 | 56 | 15 | 0 |
30 Sep 20 | 91 | 32 | 14 | 0 |
30 Jun 20 | 55 | 6 | 14 | 0 |
31 Mar 20 | 19 | -18 | 13 | 0 |
31 Dec 19 | 27 | -7 | 13 | 0 |
30 Sep 19 | 24 | 50 | 14 | 0 |
30 Jun 19 | 487 | 439 | 14 | 0 |
31 Mar 19 | 486 | 435 | 13 | 0 |
31 Dec 18 | 477 | 422 | 13 | 0 |
30 Sep 18 | 477 | 359 | 12 | 0 |
30 Jun 18 | 7 | -39 | 12 | 0 |
31 Mar 18 | 9 | -39 | 12 | 0 |
31 Dec 17 | 12 | -36 | 12 | 0 |
30 Sep 17 | 18 | -36 | 13 | 0 |
30 Jun 17 | 21 | -36 | 13 | 0 |
31 Mar 17 | 19 | -38 | 14 | 0 |
31 Dec 16 | 15 | -40 | 14 | 0 |
30 Sep 16 | 12 | -49 | 12 | 0 |
30 Jun 16 | 9 | -46 | 11 | 0 |
31 Mar 16 | 8 | -43 | 10 | 0 |
31 Dec 15 | 8 | -39 | 11 | 0 |
30 Sep 15 | 5 | -38 | 10 | 0 |
30 Jun 15 | 5 | -273 | 12 | 0 |
31 Mar 15 | 4 | -269 | 13 | 0 |
31 Dec 14 | 3 | -265 | 13 | 0 |
30 Sep 14 | 3 | -251 | 14 | 0 |
30 Jun 14 | 4 | -16 | 13 | 0 |
31 Mar 14 | 5 | -16 | 13 | 0 |
31 Dec 13 | 6 | -17 | 13 | 0 |
30 Sep 13 | 7 | -15 | 12 | 0 |
30 Jun 13 | 7 | -14 | 12 | 0 |
質の高い収益: SIGA 非現金収入 のレベルが高いです。
利益率の向上: SIGAの現在の純利益率 (50.5%)は、昨年(30.7%)よりも高くなっています。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: SIGAの収益は過去 5 年間で年間39.3%減少しました。
成長の加速: SIGAの過去 1 年間の収益成長率 ( 137.7% ) は、5 年間の平均 ( 年間-39.3%を上回っています。
収益対業界: SIGAの過去 1 年間の収益成長率 ( 137.7% ) はPharmaceuticals業界19.9%を上回りました。
株主資本利益率
高いROE: SIGAの 自己資本利益率 ( 48% ) は 傑出している と考えられます。